The present invention discloses a polypeptide comprising a
capsid protein sequence consisting of eight core regions and seven loop modification regions, wherein the eight core regions are defined, respectively, by
amino acid positions M1 to S309, P319 to R328, T340 to T342, M349 to F352, W359 to F362, V368 to Q373, T383 to T387 and T392 to N644 in the
amino acid sequence according to SEQ ID NO: 1, wherein the eight core regions of the
capsid protein sequence have at least 70 %
sequence identity to the eight core regions of the
amino acid sequence according to SEQ ID NO: 1 or SEQ ID NO: 2 at least in the range from R32 to N570, wherein the seven loop modification regions are defined, respectively, by amino acid positions A310 to I318, H329 to I339, I343 to T348, D353 to E358, A363 to D367, T374 to A382, and A388 to V391 in the amino acid sequence according to SEQ ID NO: 1, wherein at least one loop modification region of the
capsid protein sequence differs from the corresponding loop modification region of the amino acid sequences according to SEQ ID NO: 1 and SEQ ID NO: 2 at least in that the at least one loop modification region comprises -
a peptide insert sequence comprising at least 3 amino acids, so that the at least one loop modification region of the capsid protein sequence is extended with respect to the corresponding loop modification region of the amino acid sequences according to SEQ ID NO: 1 and SEQ ID NO: 2 by said number of amino acids; and / or - a
cysteine residue, and
Virus-like Nanoparticles (VLNPs) comprising such polypeptides.